Requires a subscription to Wall Street Journal. Sorry.
New Effort for Lyme Disease Vaccine Draws Early Fire
By
Sumathi Reddy
Updated July 9, 2018 3:48 p.m. ET
Efforts to bring a vaccine for Lyme disease to the market have run aground amid heated debate over the years.
Now, a European company is in the early stages of creating a vaccine for the increasingly common tick-borne disease. Lyme disease patient-advocacy groups—who disagree with the protocols used by most doctors for the diagnosis andtreatment of Lyme disease—are already raising concerns.
No comments:
Post a Comment
Please be constructive in your comments.